← EPO Patent Bulletin

3-SUBSTITUTED PIPERIDINE COMPOUNDS FOR CBL-B INHIBITION, AND USE OF A CBL-B INHIBITOR IN COMBINATION WITH A CANCER VACCINE AND/OR ONCOLYTIC VIRUS

Publication EP3953346A1 Kind: A1 Apr 01, 2026

Applicants

Nurix Therapeutics, Inc.

Inventors

SANDS, Arthur T., BENCE, Neil F., ZAPF, Christoph W., COHEN, Frederick, WANG, Chenbo, CUMMINS, Thomas, TANAKA, Hiroko, SHUNATONA, Hunter, CARDOZO, Mario, WEISS, Dahlia, GOSLING, Jennifa

IPC Classifications

C07D 401/14 20060101AFI20201016BHEP C07D 405/14 20060101ALI20201016BHEP C07D 471/04 20060101ALI20201016BHEP C07D 491/107 20060101ALI20201016BHEP A61P 35/00 20060101ALI20201016BHEP A61P 37/00 20060101ALI20201016BHEP A61K 31/454 20060101ALI20201016BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR